|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1900 USD | +0.43% |
|
-0.52% | -16.91% |
| 05-15 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.43% | -0.52% | -24.71% | -4.95% | -16.91% | -29.23% | -70.29% | -87.66% | -69.14% | 315M | |
| +0.38% | +0.98% | +15.93% | +30.58% | +9.26% | +65.65% | +117.50% | +193.11% | +6,770.18% | 56.24B | |
| +0.04% | +1.20% | -4.78% | +6.21% | +8.34% | +47.67% | +36.75% | -27.79% | - | 43.76B | |
| +3.04% | +7.05% | +2.98% | -2.78% | -3.13% | -12.15% | -18.06% | -56.95% | - | 23.32B | |
| +3.07% | +7.15% | -9.79% | -31.60% | -43.43% | -1.82% | +392.25% | +236.81% | +940.70% | 21.34B | |
| +3.22% | +2.94% | -6.44% | -13.23% | -1.97% | +24.02% | -34.00% | -76.67% | - | 15.75B | |
| +0.76% | +1.92% | -2.54% | -1.93% | -18.72% | +16.31% | -37.64% | -39.47% | +44.64% | 15.6B | |
| +0.65% | -0.27% | +4.61% | +25.36% | +19.64% | +26.80% | +174.70% | +136.96% | +590.00% | 13.18B | |
| +3.07% | +5.43% | -1.98% | -3.62% | +6.02% | +21.37% | - | - | - | 12.01B | |
| +1.92% | +2.43% | +22.28% | +53.73% | +114.89% | +112.68% | +232.59% | +1,123.61% | +402.64% | 11.87B | |
| -0.27% | +6.06% | -4.55% | +12.79% | -14.16% | +78.78% | +104.79% | +375.69% | - | 11.52B | |
| +5.87% | +14.58% | +5.70% | +40.77% | +22.07% | +422.84% | +128.93% | -5.75% | +1,311.85% | 11.42B | |
| +1.37% | +7.82% | -16.60% | -11.23% | -19.55% | -29.12% | +576.44% | +110.94% | +73.92% | 10.92B | |
| +3.86% | +16.46% | +2.98% | +25.72% | +22.93% | +140.04% | +124.20% | +256.02% | +749.02% | 10.61B | |
| +4.35% | -0.28% | -23.07% | -27.10% | -22.52% | -7.60% | +141.18% | +41.67% | - | 9.86B | |
| -0.02% | +0.01% | +20.59% | +24.64% | +22.64% | +62.19% | +185.16% | - | - | 9.75B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +32.20% | +230.83% | - | 8.19B | |
| 0.00% | +8.23% | -10.55% | -13.62% | -38.96% | - | - | - | - | 7.45B | |
| +1.63% | -1.65% | -20.16% | -30.10% | -4.86% | +32.62% | +89.75% | -46.44% | - | 7.5B | |
| +4.89% | +16.53% | +16.78% | +99.07% | +167.06% | +476.35% | +2,405.08% | -46.41% | -21.53% | 7.6B | |
| Average | +1.95% | +4.28% | -1.67% | +8.93% | +10.43% | +76.18% | +254.53% | +136.38% | +1,079.23% | 15.41B | |
| Weighted average by Cap. | +1.65% | +3.94% | +1.41% | +10.06% | +7.50% | +64.25% | +182.80% | +130.67% | +2,750.90% |
- Stock Market
- Stocks
- NWBO Stock
- Sector Northwest Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
